Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum DiaMedica Therapeutics Inc DMAC

Healthcare Biotechnology
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in... see more

Bullboard (NDAQ:DMAC)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by StockscoutXon Feb 03, 2021 11:31am

Here is something to think about to diversify.

Aristotle - 10 Cancers - One Sample of Blood Unlimited Possibilities. It's on the Toronto Stock Exchange in Canada. QR is about to be released soon as the deployment of Aristotle. The ticker ...more  
216
Post by TradeSaver2on Nov 10, 2020 1:43pm

C'mon Jinxmom

you spinless loser...enjoy your cr@p life...end it....we are having fun! 
182
Post by StockscoutXon Sep 15, 2020 7:06pm

DiaMedica Therapeutics to Present at Conference

DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020 Link
181
Post by StockscoutXon Sep 15, 2020 7:03pm

DiaMedica Announces First Patients Dosed

DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study Link
189
Post by Carlsoncrewon Jun 19, 2020 12:18pm

over 100

Haha jinxmom - you are a loser. go off yourself. 
226
Post by Pugsrock2on May 13, 2020 7:25pm

Poaitive Results

Tomorrow should be good
207
Discussion
Post by Pugsrock2on Feb 27, 2020 6:34pm

Pounded

Hammered in the last few trading sessions
130
Discussion
Post by Jinkmomon Feb 23, 2020 8:54pm

Wondering

Will this company ever reach 100M market cap. Been a decade. 
120
Post by Roadster2on Feb 23, 2020 6:20pm

Another Stroke Drug with PHASE III

A pivotal moment’: Canadian-developed drug shows dramatic outcomes in reducing damage caused by strokes. February 20, 2020, The Globe and Mail A Canadian-developed drug has shown dramatic outcomes in ...more  
210
Comment by Pugsrock2on Jan 28, 2020 7:41pm

RE:Huh

I would be nervous too. Go short
117
Discussion
Post by MNdude20on Jan 28, 2020 3:39pm

Huh

If the Chief scientific officer quits from a public company why wouldn't that be written in a press release? Conference call good enough? sorry not sure how this works. Nervous about my ...more  
254
Discussion
Post by Roadster2on Jan 03, 2020 7:45am

New $ 50 million shelf registration filed

Will they sell entire $ 50 million? At what price?
185
Post by RockLobster1on Dec 17, 2019 8:40pm

First Patient Dosed in REDUX Phase II Clinical Trial

DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease Business Wire ...more  
162
Comment by TrueNorth911on Dec 11, 2019 12:50pm

RE:Check on Reality of the Situation--Another reverse split?

Honestly.... I need to thank you. Your my BUY signal. Everytime you pop up on this board, you give me all the info I need to BUY more. Thanks!
135
Discussion
Comment by TrueNorth911on Dec 11, 2019 12:21pm

RE:Check on Reality of the Situation--Another reverse split?

Was wondering where you've been buttercup. Same ole story over and over... Your copy and paste buttons must be worn off by now. Keep dreaming that we'll give our shares away so that you can ...more  
139
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities